Marinomed Biotech AG (WBO:MARI) Total Debt per Share : €14.30 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Marinomed Biotech AG Total Debt per Share?

€14.30 (As of Dec. 2023)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Marinomed Biotech AG's Total Debt Per Share for the quarter that ended in Dec. 2023 was €14.30.

Marinomed Biotech AG Total Debt per Share Historical Data

The historical data trend for Marinomed Biotech AG's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marinomed Biotech AG Total Debt per Share Chart

Marinomed Biotech AG Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Debt per Share

Get a 7-Day Free Trial

3.16

8.70

10.67

15.02

14.30

Marinomed Biotech AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Debt per Share	Get a 7-Day Free Trial															15.02	14.41	14.19	14.03	14.30

Marinomed Biotech AG Total Debt per Share Calculation

Marinomed Biotech AG's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(14.84	+	6.96)	/	1.52
	=	14.30

Marinomed Biotech AG's Total Debt Per Share for the quarter that ended in Dec. 2023 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(14.84	+	6.96)	/	1.52
	=	14.30

Marinomed Biotech AG Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Marinomed Biotech AG's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Marinomed Biotech AG (WBO:MARI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinomed Biotech AG (WBO:MARI) » Definitions » Total Debt per Share

Comparable Companies

Traded in Other Exchanges

93Z:Germany

Address

Hovengasse 25, Korneuburg, AUT, 2100

Website

https://www.marinomed.com

Marinomed Biotech AG is a biopharmaceutical company focusing on the development of products in the field of respiratory and ophthalmological diseases. The products marketed by the company are based on its platform Carragelose and Marinosolv. The company develops products for cough, cold, influenza, allergic rhinitis, and ophthalmic diseases. Its product offerings include virus-blocking nasal sprays, virus-blocking decongestant nasal sprays, virus-blocking lozenges, and virus-blocking throat sprays. The company has two reportable segments which are Virology, Immunology, and other, the majority of revenue generates from the virology segment.

Marinomed Biotech AG (WBO:MARI) Headlines

No Headlines